lizofit
Introduction to lizofit
lizofit is a medication available in tablet form primarily used to treat severe bacterial infections. It is particularly effective against resistant bacteria such as MRSA, which do not respond to many antibiotics.
Composition of lizofit
lizofit contains the active ingredient Linezolid, which works by inhibiting bacterial protein synthesis, thereby stopping the growth and multiplication of bacteria.
Uses of lizofit
- Treatment of severe bacterial infections
- Effective against pneumonia (lung infection)
- Used for skin infections
- Particularly effective against MRSA
Side effects of lizofit
- Common side effects: Diarrhea, headache, nausea
- Serious side effects: Syndrome serotoninérgico, bone marrow suppression
Precautions of lizofit
lizofit may cause serious conditions like syndrome serotoninérgico when taken with certain antidepressants. It can also lead to bone marrow suppression, requiring regular blood tests. Always consult your doctor before use.
How to Take lizofit
The usual dosage of lizofit for adults is 600 mg taken orally twice a day, every 12 hours, for 10 to 14 days. It can be taken with or without food. Follow your doctor’s advice for the correct usage.
Conclusion of lizofit
lizofit, containing Linezolid, belongs to the therapeutic class of antibiotics and is manufactured to treat severe bacterial infections, including those caused by resistant strains like MRSA. It is essential to follow medical guidance for its use to ensure safety and effectiveness.

Similar Medicines
More medicines by Intas Pharmaceuticals Ltd
Available in 2 variations

Lizofit 200mg Infusion
bottle of 300 ml Infusion

Lizofit 600mg Tablet
strip of 4 tablets
Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.
lizofit
Prescription Required
Manufacturer :
Intas Pharmaceuticals LtdComposition :
linezolid









